Ascendis Pharma A/S
ASND
$223.82
-$3.59-1.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 24.86% | -9.34% | 109.32% | 62.03% | 31.21% |
| Total Receivables | 0.79% | 207.64% | 64.67% | 12.04% | 197.99% |
| Inventory | 15.68% | 19.70% | 32.38% | 26.19% | 32.52% |
| Prepaid Expenses | 35.26% | -4.61% | 2.35% | -20.63% | -31.37% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 18.55% | 9.96% | 66.50% | 39.01% | 41.40% |
|
|
|||||
| Total Current Assets | 18.55% | 9.96% | 66.50% | 39.01% | 41.40% |
| Net Property, Plant & Equipment | 68.28% | 9.77% | -1.45% | -13.57% | -16.43% |
| Long-term Investments | 13.41% | -- | -- | -- | -6.34% |
| Goodwill | 13.41% | -- | -- | -- | -6.34% |
| Total Other Intangibles | -54.26% | -4.13% | -0.76% | -8.95% | -45.97% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 432.05% | 50.97% | 35.93% | 25.03% | 2.03% |
| Total Assets | 25.24% | 11.06% | 57.25% | 32.51% | 33.82% |
|
|
|||||
| Total Accounts Payable | 6.66% | 9.86% | 3.21% | -10.58% | -4.53% |
| Total Accrued Expenses | -- | 20.27% | 65.69% | 68.00% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.25% | 12.81% | 11.72% | 11.71% | 9.29% |
| Total Finance Division Other Current Liabilities | 74.47% | 46.35% | 38.54% | 12.90% | 66.94% |
| Total Other Current Liabilities | 74.47% | 46.35% | 38.54% | 12.90% | 66.94% |
| Total Current Liabilities | 33.59% | 23.77% | 20.89% | 11.03% | 15.46% |
|
|
|||||
| Total Current Liabilities | 33.59% | 23.77% | 20.89% | 11.03% | 15.46% |
| Long-Term Debt | 0.25% | -1.19% | 102.23% | 90.23% | 94.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 91.70% | 16.98% | 2.26% | -4.56% | -14.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -0.58% | -15.85% | -10.82% | -30.16% | -2.53% |
| Total Liabilities | 29.31% | 17.36% | 29.51% | 20.45% | 23.94% |
|
|
|||||
| Common Stock & APIC | 17.44% | 8.41% | 26.22% | 14.81% | 7.80% |
| Retained Earnings | -19.64% | -11.36% | -18.12% | -11.36% | -5.29% |
| Treasury Stock & Other | -224.61% | -269.45% | -63.15% | 144.90% | 172.03% |
| Total Common Equity | -74.69% | -88.17% | 35.98% | 20.16% | 32.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -74.69% | -88.17% | 35.98% | 20.16% | 32.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -74.69% | -88.17% | 35.98% | 20.16% | 32.04% |
|
|
|||||